Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 6—June 2005

Community-associated Methicillin-resistant Staphylococcus aureus in Pediatric Patients

Theresa J. Ochoa*, John Mohr*, Audrey Wanger*†, James R. Murphy*, and Gloria P. Heresi*Comments to Author 
Author affiliations: *University of Texas Health Science Center at Houston, Houston, Texas, USA; †Memorial Hermann Hospital, Houston, Texas, USA

Main Article

Table 2

Site of infection with CA-MRSA or CA-MSSA*

Site No. MRSA (n = 159), (%) No. MSSA (n = 80), (%) p value
Abscess 80 (50.3) 23 (28.7) <0.01
Lymphadenitis 35 (22.0) 13 (16.2) NS
Pneumonia 17 (10.7) 13 (16.2) NS
Complicated pneumonia† 12/17 (70.6) 2/13 (15.4) <0.01
Cellulitis 12 (7.5) 8 (10.0) NS
Osteoarticular‡ 10 (6.3) 8 (10.0) NS
Other§ 5 (3.1) 15 (18.7) ND

*CA, community-associated; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible S. aureus; NS, not significant; ND, not done (various diagnosis grouped).
†Empyema, necrotizing pneumonia, pneumatocele, or pneumothorax.
‡Osteomyelitis or septic arthritis.
§Sinusitis, preseptal and septal cellulitis, retropharyngeal and mediastinal abscess, urinary tract infection, toxic shock syndrome, isolated bacteremia.

Main Article

Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.